Aravive (ARAV) has a profit margin of -1027.73%, below the Healthcare sector average of 21.34%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2023
Trailing 12 months ending Sep 2023
The latest profit margin for ARAV is -1027.73% as of September 2023. That compares with -695.57% in the prior-year period — down 47.8% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Aravive's historical trend and sector peers before judging valuation or financial health.
Over the past year, ARAV's profit margin moved from -695.57% to -1027.73% — a 47.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aravive's valuation or profitability profile.
Against Healthcare companies, ARAV currently prints -1027.73% for profit margin, while the sector average sits near 21.34%. That is roughly 4917.1% below the sector mean. Large gaps often invite a closer look at Aravive's growth, margins, and balance sheet.
Profit Margin shows how effectively Aravive converts resources into returns. At -1027.73%, ARAV may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -695.57% in the prior-year period — down 47.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ARAV's profit margin (-1027.73%), review year-over-year change from -695.57%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.